E Longeval

577 total citations
17 papers, 465 citations indexed

About

E Longeval is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E Longeval has authored 17 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E Longeval's work include Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Estrogen and related hormone effects (5 papers). E Longeval is often cited by papers focused on Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Estrogen and related hormone effects (5 papers). E Longeval collaborates with scholars based in Belgium, France and Switzerland. E Longeval's co-authors include Jean Klášterský, Guy Leclercq, Richard Sylvester, Jean-Claude Heuson, W Mattheiem, Claude Nicaise, Pierre Stryckmans, Nicole Legros, Marcel Rozencweig and Danièle Weerts and has published in prestigious journals such as Cancer, Journal of Endocrinology and Cancer Treatment Reviews.

In The Last Decade

E Longeval

16 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Longeval Belgium 10 294 146 128 115 112 17 465
K Fischerman Denmark 11 192 0.7× 80 0.5× 95 0.7× 78 0.7× 88 0.8× 23 480
E. Mickiewicz Argentina 9 372 1.3× 166 1.1× 213 1.7× 72 0.6× 34 0.3× 15 639
R. C. Horns United States 6 176 0.6× 57 0.4× 99 0.8× 159 1.4× 35 0.3× 11 411
Koichi Motojima Japan 13 386 1.3× 76 0.5× 39 0.3× 104 0.9× 110 1.0× 27 558
G Mathé France 9 170 0.6× 58 0.4× 40 0.3× 120 1.0× 37 0.3× 48 386
H. S. Levin United States 9 84 0.3× 181 1.2× 74 0.6× 133 1.2× 27 0.2× 15 396
Nicoletta Ravarino Italy 11 244 0.8× 82 0.6× 83 0.6× 54 0.5× 64 0.6× 25 517
Fukashi Doi Japan 7 154 0.5× 46 0.3× 36 0.3× 108 0.9× 49 0.4× 11 419
C.M. Lalanne France 10 102 0.3× 47 0.3× 100 0.8× 94 0.8× 20 0.2× 26 330
Caroline Archer United Kingdom 11 244 0.8× 159 1.1× 45 0.4× 124 1.1× 20 0.2× 21 522

Countries citing papers authored by E Longeval

Since Specialization
Citations

This map shows the geographic impact of E Longeval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Longeval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Longeval more than expected).

Fields of papers citing papers by E Longeval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Longeval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Longeval. The network helps show where E Longeval may publish in the future.

Co-authorship network of co-authors of E Longeval

This figure shows the co-authorship network connecting the top 25 collaborators of E Longeval. A scholar is included among the top collaborators of E Longeval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Longeval. E Longeval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gris, P, et al.. (1990). [Leukemoid reaction and hypercalcemia in carcinoma of the bladder].. PubMed. 11(3). 59–62. 3 indexed citations
2.
Focan, C., A Baudoux, M. Beauduin, et al.. (1989). Adjuvant Treatment with High Dose Medroxyprogesterone Acetate in Node-Negative Early Breast Cancer A 3-year Interim Report on a Randomized Trial (I). Acta Oncologica. 28(2). 237–240. 6 indexed citations
3.
Sculier, Jean‐Paul, Jean Klášterský, D. Becquart, et al.. (1988). Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer. European Journal of Cancer and Clinical Oncology. 24(3). 519–526. 10 indexed citations
4.
Focan, C., A Baudoux, M. Beauduin, et al.. (1987). Improvement of hematological and general tolerance to CMF by high-dose medroxyprogesterone acetate (HD-MPA) adjuvant treatment for primary node positive breast cancer (analysis of 100 patients).. PubMed. 6(5). 1095–9. 6 indexed citations
5.
Klášterský, Jean, Nicholas D. Nguyen, D. Becquart, et al.. (1986). [Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results].. PubMed. 15(18). 830–4. 1 indexed citations
6.
Sculier, Jean‐Paul, D. Becquart, G. Vandermoten, et al.. (1985). Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium). Cancer. 56(1). 71–75. 16 indexed citations
7.
Klášterský, Jean, E Longeval, Claude Nicaise, & Danièle Weerts. (1982). Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma. Cancer Treatment Reviews. 9. 133–138. 17 indexed citations
8.
9.
10.
Bleiberg, Harry, Marcel Rozencweig, J. Michel, et al.. (1981). Phase II trial with chlorozotocin in advanced colorectal cancer. European Journal of Cancer and Clinical Oncology. 17(8). 863–866. 3 indexed citations
11.
Longeval, E, et al.. (1980). High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).. PubMed. 64(12). 1341–6. 66 indexed citations
12.
Borkowski, Abraham, M. L’Hermite, Pierre Dor, et al.. (1977). STEROID SEX HORMONES AND PROLACTIN IN POSTMENOPAUSAL WOMEN WITH GENERALIZED MAMMARY CARCINOMA DURING PROLONGED DEXAMETHASONE TREATMENT. Journal of Endocrinology. 73(2). 235–246. 12 indexed citations
13.
Heuson, Jean-Claude, et al.. (1977). Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer. Cancer. 39(5). 1971–1977. 112 indexed citations
14.
Bleiberg, Harry, Marcel Rozencweig, E Longeval, J Frühling, & Viviane De Maertelaer. (1977). Peritoneoscopy as a diagnostic supplement to liver function tests and liver scan in patients with carcinoma.. PubMed. 145(6). 821–5. 9 indexed citations
15.
Leclercq, Guy, et al.. (1977). Estrogen and progesterone receptors in human breast cancer.. 42 indexed citations
16.
Longeval, E, et al.. (1976). Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemia.. PubMed. 59(6). 1173–5. 2 indexed citations
17.
Longeval, E, et al.. (1975). Early diagnosis of metastases in the epidural space. Acta Neurochirurgica. 31(3-4). 177–184. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Fischerman Breakdown of academic impact, for papers by E. Mickiewicz Breakdown of academic impact, for papers by R. C. Horns Breakdown of academic impact, for papers by Koichi Motojima Breakdown of academic impact, for papers by G Mathé Breakdown of academic impact, for papers by H. S. Levin Breakdown of academic impact, for papers by Nicoletta Ravarino Breakdown of academic impact, for papers by Fukashi Doi Breakdown of academic impact, for papers by C.M. Lalanne Breakdown of academic impact, for papers by Caroline Archer
Rankless by CCL
2026